SmarterDividends
HQL

Abrdn Life Sciences Investors

HQL

Financial Services · Stock · quarterly payer

$19.57

Undervalued · +223% Add to Portfolio

Forward Yield

11.62%

Annual Dividend

$2.24

Payout Ratio

29%

5-Yr Growth

7.8%

Ex-Date

Aug 24, 2026

Frequency

Quarterly

Summary

As of September 2026, Abrdn Life Sciences Investors (HQL) yields 11.62% ($2.24 per share annually), with a blended fair-value estimate of $63.78 — +223% upside, so it screens as undervalued. Dividend safety grade: C (63/100).

Is HQL a good dividend stock?

Yes, with caveats

Abrdn Life Sciences Investors (HQL) pays a quarterly dividend yielding 11.62% ($2.24/yr), with 0 years of growth and a dividend-safety grade of C. It's a solid income payer, but check the caveats below before buying.

Advantages

  • Comfortable payout ratio (29%)
  • Strong 7.8% 5-yr dividend growth

Risks

  • Cut its dividend in 2025
  • Very high yield can signal elevated risk
  • Share price is down over the past 5 years

Key Data

Dividend Yield
11.62%
Payout Ratio
29%
Annual Dividend
$2.24
5-Yr Avg Growth
7.8%
Ex-Dividend Date
Aug 24, 2026
Years of Growth
0
Frequency
quarterly
Beta
0.72
Market Cap
$595.1M
P/E Ratio
2.9
5-Yr Total Return
-5%
52-Week Range
$13.88 – $22.67
Dividend Safety
C · 63/100
Ever Cut?
Yes (2025)
HQL ex-dividend date & scheduleNext ex-date Aug 24, 2026 · full ex-dividend historyView →

Frequently Asked Questions